Your session is about to expire
← Back to Search
Combined gastric mucosal ablation with endoscopic sleeve gastroplasty for Obesity
N/A
Recruiting
Research Sponsored by True You Weight Loss
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months, 6 months, 9 months, 12 months, 15 months, 24 months
Awards & highlights
Summary
The purpose of this study is to construct a multi-site, prospective registry to evaluate the clinical outcomes of patients who have undergone combined gastric mucosal ablation with endoscopic sleeve gastroplasty at True You Weight Loss.
Eligible Conditions
- Obesity
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months, 6 months, 9 months, 12 months, 15 months, 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months, 6 months, 9 months, 12 months, 15 months, 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Change in Body Mass Index (BMI) from Baseline
Percent Change in Total Body Weight Loss (TBWL) from Baseline
Percent Excess Weight Loss from Baseline (EWL)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Combined gastric mucosal ablation with endoscopic sleeve gastroplastyExperimental Treatment1 Intervention
All patients included in the multi-site, prospective registry will undergo the combined gastric mucosal ablation with endoscopic sleeve gastroplasty procedure, regardless of their participation in the research study.
Find a Location
Who is running the clinical trial?
True You Weight LossLead Sponsor
4 Previous Clinical Trials
268 Total Patients Enrolled
4 Trials studying Obesity
268 Patients Enrolled for Obesity
Share this study with friends
Copy Link
Messenger